Avadel Pharmaceuticals Plc (AVDL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVDL? Forum Prognose

Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	39.71% 27.18	19.45	7.014	1.496	-
Cost Of Revenue	119.62% 1.522	0.693	0.117	0.036	-
Gross Profit	36.76% 25.66	18.76	6.897	1.46	-
Operating Expenses	18.39% 51.69	43.66	42.01	51.00	28.30
Benefits Costs and Expenses	12.59% 54.43	48.34	43.20	65.84	31.36
Costs And Expenses	19.29% 54.43	67.43	42.01	51.00	28.30
Depreciation and Amortization	3,106% 0.541	-0.018	0.595	0.601	0.588
Operating Income/Loss	4.56% -26.04	-24.90	-35.11	-49.54	-28.30
Income/Loss From Continuing Operations Before Tax	5.67% -27.25	-28.89	-36.19	-64.34	-31.36
Income Tax Expense/Benefit	193.00% 0.093	-0.10	0.089	0.09	-0.58
Income/Loss From Continuing Operations After Tax	5.02% -27.34	-28.79	-36.27	-64.43	-30.78
Net Income/Loss	5.02% -27.34	-28.79	-36.27	-64.43	-30.78
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,727% 91.69	3.243	89.38	77.25	63.89
Diluted Average Shares	2,727% 91.69	3.243	89.38	77.25	63.89
Basic Earnings Per Share	3.45% -0.30	-0.29	-0.41	-0.83	-0.48
Diluted Earnings Per Share	3.45% -0.30	-0.29	-0.41	-0.83	-0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$30.10

2.14%

ELAN

$12.04

0.17%

LNTH

$94.05

2.82%

ITCI

$126.50

0.24%

VTRS

$11.33

0.27%

NBIX

$145.88

1.83%